Global Systemic Aspergillosis and Systemic Candidasis Market Insights and Forecast to 2026
Table of Contents1 Study Coverage
1.1 Systemic Aspergillosis and Systemic Candidasis Product Introduction
1.2 Market Segments
1.3 Key Systemic Aspergillosis and Systemic Candidasis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Type
1.4.2 Voriconazole
1.4.3 Liposomal Amphotericin B
1.4.4 Systemic Oral Azoles
1.4.5 Topical Antifungal Agents
1.4.6 Other
1.5 Market by Application
1.5.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Application
1.5.2 CPA
1.5.3 ABPA
1.5.4 Gastrointestinal Candidiasis
1.5.5 Genitourinary Tract Candidiasis
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size, Estimates and Forecasts
2.1.1 Global Systemic Aspergillosis and Systemic Candidasis Revenue 2015-2026
2.1.2 Global Systemic Aspergillosis and Systemic Candidasis Sales 2015-2026
2.2 Global Systemic Aspergillosis and Systemic Candidasis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Systemic Aspergillosis and Systemic Candidasis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Systemic Aspergillosis and Systemic Candidasis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Systemic Aspergillosis and Systemic Candidasis Competitor Landscape by Players
3.1 Systemic Aspergillosis and Systemic Candidasis Sales by Manufacturers
3.1.1 Systemic Aspergillosis and Systemic Candidasis Sales by Manufacturers (2015-2020)
3.1.2 Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Manufacturers (2015-2020)
3.2 Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturers
3.2.1 Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturers (2015-2020)
3.2.2 Systemic Aspergillosis and Systemic Candidasis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Systemic Aspergillosis and Systemic Candidasis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Systemic Aspergillosis and Systemic Candidasis Revenue in 2019
3.2.5 Global Systemic Aspergillosis and Systemic Candidasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Systemic Aspergillosis and Systemic Candidasis Price by Manufacturers
3.4 Systemic Aspergillosis and Systemic Candidasis Manufacturing Base Distribution, Product Types
3.4.1 Systemic Aspergillosis and Systemic Candidasis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Systemic Aspergillosis and Systemic Candidasis Product Type
3.4.3 Date of International Manufacturers Enter into Systemic Aspergillosis and Systemic Candidasis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size by Type (2015-2020)
4.1.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020)
4.1.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2015-2020)
4.1.3 Systemic Aspergillosis and Systemic Candidasis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Type (2021-2026)
4.2.1 Global Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Type (2021-2026)
4.2.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Type (2021-2026)
4.2.3 Systemic Aspergillosis and Systemic Candidasis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Systemic Aspergillosis and Systemic Candidasis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size by Application (2015-2020)
5.1.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020)
5.1.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2015-2020)
5.1.3 Systemic Aspergillosis and Systemic Candidasis Price by Application (2015-2020)
5.2 Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Application (2021-2026)
5.2.1 Global Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Application (2021-2026)
5.2.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Application (2021-2026)
5.2.3 Global Systemic Aspergillosis and Systemic Candidasis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Systemic Aspergillosis and Systemic Candidasis by Country
6.1.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Country
6.1.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Type
6.3 North America Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Application
7 Europe
7.1 Europe Systemic Aspergillosis and Systemic Candidasis by Country
7.1.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Country
7.1.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Type
7.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis by Region
8.1.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Region
8.1.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Type
8.3 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Systemic Aspergillosis and Systemic Candidasis by Country
9.1.1 Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Country
9.1.2 Latin America Systemic Aspergillosis and Systemic Candidasis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Type
9.3 Central & South America Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis by Country
10.1.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Country
10.1.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Type
10.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Products Offered
11.1.5 Novartis AG Related Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Description and Business Overview
11.2.3 Pfizer, Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Products Offered
11.2.5 Pfizer, Inc Related Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Description and Business Overview
11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Products Offered
11.3.5 Sanofi-Aventis Related Developments
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Corporation Information
11.4.2 Merck & Co., Inc Description and Business Overview
11.4.3 Merck & Co., Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Products Offered
11.4.5 Merck & Co., Inc Related Developments
11.5 Enzon Pharmaceuticals, Inc
11.5.1 Enzon Pharmaceuticals, Inc Corporation Information
11.5.2 Enzon Pharmaceuticals, Inc Description and Business Overview
11.5.3 Enzon Pharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Products Offered
11.5.5 Enzon Pharmaceuticals, Inc Related Developments
11.6 Bayer AG
11.6.1 Bayer AG Corporation Information
11.6.2 Bayer AG Description and Business Overview
11.6.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer AG Systemic Aspergillosis and Systemic Candidasis Products Offered
11.6.5 Bayer AG Related Developments
11.7 Astellas Pharma, Inc
11.7.1 Astellas Pharma, Inc Corporation Information
11.7.2 Astellas Pharma, Inc Description and Business Overview
11.7.3 Astellas Pharma, Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Products Offered
11.7.5 Astellas Pharma, Inc Related Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Corporation Information
11.8.2 GlaxoSmithKline plc Description and Business Overview
11.8.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Products Offered
11.8.5 GlaxoSmithKline plc Related Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Description and Business Overview
11.9.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Systemic Aspergillosis and Systemic Candidasis Products Offered
11.9.5 Abbott Related Developments
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Products Offered
11.1.5 Novartis AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Systemic Aspergillosis and Systemic Candidasis Market Estimates and Projections by Region
12.1.1 Global Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Regions 2021-2026
12.1.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Regions 2021-2026
12.2 North America Systemic Aspergillosis and Systemic Candidasis Market Size Forecast (2021-2026)
12.2.1 North America: Systemic Aspergillosis and Systemic Candidasis Sales Forecast (2021-2026)
12.2.2 North America: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast (2021-2026)
12.2.3 North America: Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Country (2021-2026)
12.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Size Forecast (2021-2026)
12.3.1 Europe: Systemic Aspergillosis and Systemic Candidasis Sales Forecast (2021-2026)
12.3.2 Europe: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast (2021-2026)
12.3.3 Europe: Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Region (2021-2026)
12.5 Latin America Systemic Aspergillosis and Systemic Candidasis Market Size Forecast (2021-2026)
12.5.1 Latin America: Systemic Aspergillosis and Systemic Candidasis Sales Forecast (2021-2026)
12.5.2 Latin America: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast (2021-2026)
12.5.3 Latin America: Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Systemic Aspergillosis and Systemic Candidasis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Systemic Aspergillosis and Systemic Candidasis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Systemic Aspergillosis and Systemic Candidasis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Systemic Aspergillosis and Systemic Candidasis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Systemic Aspergillosis and Systemic Candidasis Market Segments
Table 2. Ranking of Global Top Systemic Aspergillosis and Systemic Candidasis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Voriconazole
Table 5. Major Manufacturers of Liposomal Amphotericin B
Table 6. Major Manufacturers of Systemic Oral Azoles
Table 7. Major Manufacturers of Topical Antifungal Agents
Table 8. Major Manufacturers of Other
Table 9. Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Systemic Aspergillosis and Systemic Candidasis Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Systemic Aspergillosis and Systemic Candidasis Sales by Regions 2015-2020 (K Units)
Table 12. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Regions (2015-2020)
Table 13. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Systemic Aspergillosis and Systemic Candidasis Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Systemic Aspergillosis and Systemic Candidasis Sales Share by Manufacturers (2015-2020)
Table 16. Global Systemic Aspergillosis and Systemic Candidasis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Systemic Aspergillosis and Systemic Candidasis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Aspergillosis and Systemic Candidasis as of 2019)
Table 18. Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Systemic Aspergillosis and Systemic Candidasis Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Systemic Aspergillosis and Systemic Candidasis Price (2015-2020) (USD/Unit)
Table 21. Systemic Aspergillosis and Systemic Candidasis Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Systemic Aspergillosis and Systemic Candidasis Product Type
Table 23. Date of International Manufacturers Enter into Systemic Aspergillosis and Systemic Candidasis Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 26. Global Systemic Aspergillosis and Systemic Candidasis Sales Share by Type (2015-2020)
Table 27. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Systemic Aspergillosis and Systemic Candidasis Revenue Share by Type (2015-2020)
Table 29. Systemic Aspergillosis and Systemic Candidasis Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 31. Global Systemic Aspergillosis and Systemic Candidasis Sales Share by Application (2015-2020)
Table 32. North America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2015-2020) (K Units)
Table 33. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2015-2020)
Table 34. North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2015-2020)
Table 36. North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 37. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Table 38. North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 39. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Table 40. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Country (2015-2020) (K Units)
Table 41. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2015-2020)
Table 42. Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2015-2020)
Table 44. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 45. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Table 46. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 47. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Table 56. Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2015-2020) (K Units)
Table 57. Latin America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2015-2020)
Table 60. Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 61. Latin America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Table 62. Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 63. Latin America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Table 72. Novartis AG Corporation Information
Table 73. Novartis AG Description and Major Businesses
Table 74. Novartis AG Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Novartis AG Product
Table 76. Novartis AG Recent Development
Table 77. Pfizer, Inc Corporation Information
Table 78. Pfizer, Inc Description and Major Businesses
Table 79. Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Pfizer, Inc Product
Table 81. Pfizer, Inc Recent Development
Table 82. Sanofi-Aventis Corporation Information
Table 83. Sanofi-Aventis Description and Major Businesses
Table 84. Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Sanofi-Aventis Product
Table 86. Sanofi-Aventis Recent Development
Table 87. Merck & Co., Inc Corporation Information
Table 88. Merck & Co., Inc Description and Major Businesses
Table 89. Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Merck & Co., Inc Product
Table 91. Merck & Co., Inc Recent Development
Table 92. Enzon Pharmaceuticals, Inc Corporation Information
Table 93. Enzon Pharmaceuticals, Inc Description and Major Businesses
Table 94. Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Enzon Pharmaceuticals, Inc Product
Table 96. Enzon Pharmaceuticals, Inc Recent Development
Table 97. Bayer AG Corporation Information
Table 98. Bayer AG Description and Major Businesses
Table 99. Bayer AG Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Bayer AG Product
Table 101. Bayer AG Recent Development
Table 102. Astellas Pharma, Inc Corporation Information
Table 103. Astellas Pharma, Inc Description and Major Businesses
Table 104. Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Astellas Pharma, Inc Product
Table 106. Astellas Pharma, Inc Recent Development
Table 107. GlaxoSmithKline plc Corporation Information
Table 108. GlaxoSmithKline plc Description and Major Businesses
Table 109. GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. GlaxoSmithKline plc Product
Table 111. GlaxoSmithKline plc Recent Development
Table 112. Abbott Corporation Information
Table 113. Abbott Description and Major Businesses
Table 114. Abbott Systemic Aspergillosis and Systemic Candidasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Abbott Product
Table 116. Abbott Recent Development
Table 117. Global Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Regions (2021-2026) (K Units)
Table 118. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Country (2021-2026) (K Units)
Table 122. North America: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Country (2021-2026) (K Units)
Table 124. Europe: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Region (2021-2026) (K Units)
Table 126. Asia Pacific: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Country (2021-2026) (K Units)
Table 128. Latin America: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Systemic Aspergillosis and Systemic Candidasis Sales Forecast by Country (2021-2026) (K Units)
Table 130. Middle East and Africa: Systemic Aspergillosis and Systemic Candidasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Systemic Aspergillosis and Systemic Candidasis Players
Table 135. Systemic Aspergillosis and Systemic Candidasis Customers List
Table 136. Systemic Aspergillosis and Systemic Candidasis Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of FiguresFigure 1. Systemic Aspergillosis and Systemic Candidasis Product Picture
Figure 2. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type in 2020 & 2026
Figure 3. Voriconazole Product Picture
Figure 4. Liposomal Amphotericin B Product Picture
Figure 5. Systemic Oral Azoles Product Picture
Figure 6. Topical Antifungal Agents Product Picture
Figure 7. Other Product Picture
Figure 8. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application in 2020 & 2026
Figure 9. CPA
Figure 10. ABPA
Figure 11. Gastrointestinal Candidiasis
Figure 12. Genitourinary Tract Candidiasis
Figure 13. Other
Figure 14. Systemic Aspergillosis and Systemic Candidasis Report Years Considered
Figure 15. Global Systemic Aspergillosis and Systemic Candidasis Market Size 2015-2026 (US$ Million)
Figure 16. Global Systemic Aspergillosis and Systemic Candidasis Sales 2015-2026 (K Units)
Figure 17. Global Systemic Aspergillosis and Systemic Candidasis Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2015-2020)
Figure 19. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region in 2019
Figure 20. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region (2015-2020)
Figure 21. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region in 2019
Figure 22. Global Systemic Aspergillosis and Systemic Candidasis Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Systemic Aspergillosis and Systemic Candidasis Revenue in 2019
Figure 24. Systemic Aspergillosis and Systemic Candidasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2015-2020)
Figure 26. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type in 2019
Figure 27. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Type (2015-2020)
Figure 28. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Type in 2019
Figure 29. Global Systemic Aspergillosis and Systemic Candidasis Market Share by Price Range (2015-2020)
Figure 30. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2015-2020)
Figure 31. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application in 2019
Figure 32. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Application (2015-2020)
Figure 33. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Application in 2019
Figure 34. North America Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country in 2019
Figure 37. North America Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country in 2019
Figure 38. U.S. Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Systemic Aspergillosis and Systemic Candidasis Market Share by Type in 2019
Figure 43. North America Systemic Aspergillosis and Systemic Candidasis Market Share by Application in 2019
Figure 44. Europe Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country in 2019
Figure 47. Europe Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country in 2019
Figure 48. Germany Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Systemic Aspergillosis and Systemic Candidasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Systemic Aspergillosis and Systemic Candidasis Sales Growth Rate (2015-2020